Search

everythinglearnresearchcommunity

for

Search:↓

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

A new rat strain with a specific gene mutation causes hair loss and kidney issues.

Early diagnosis and management of congenital heart block in mothers with autoimmune conditions are crucial for improving neonatal outcomes.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Thyroid disorders, especially autoimmune ones, are very common in the studied group.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

A 22-year-old's gray hair partially turned back to its original color without known causes.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Vitiligo is a skin condition causing white patches, likely due to an autoimmune issue.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Neonatal lupus symptoms usually resolve, but some children may develop other autoimmune diseases later.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Acne keloidalis is a chronic skin condition on the back of the neck in young black men, needing surgery for severe cases.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Vitiligo often starts young, is linked to family history and stress, and requires comprehensive care including psychological support.

Ginkgo biloba polysaccharides may reduce inflammation and promote hair growth in mice with hair loss.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

COVID-19 may trigger systemic lupus erythematosus in some people.